EUVIMEDEUVIMED entdecken
Open Access

Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving Strategy

Shih-Chao Hsu, Sheng-Hsien Chen, Te-Hong Chen, Wei-Fan Hsu, Hung-Wei Wang, Chun-Chieh Yeh, Horng-Ren Yang, Hsueh-Chou Lai, Long-Bin Jeng

Annals of Transplantation · 2026

DOI: 10.12659/aot.952135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Transplantation, 2026. Verfasst von Shih-Chao Hsu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, China Medical University Hospital, Taichung City, Taiwan. Hauptthemen laut MEDLINE: Liver Transplantation, Liver Neoplasms, Carcinoma, Hepatocellular, Neoplasm Recurrence, Local. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationLiver NeoplasmsCarcinoma, HepatocellularNeoplasm Recurrence, LocalImmune Checkpoint InhibitorsImmunosuppressive AgentsHumansFemaleMaleRetrospective StudiesMiddle AgedAdultImmunosuppression TherapyAgedGraft RejectionTreatment Outcome

Substanzen

Immune Checkpoint InhibitorsImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Surgery, China Medical University Hospital, Taichung City, Taiwan.
  • Organ Transplant Center, China Medical University Hospital, Taichung City, Taiwan.
  • Division of Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital, Taichung City, Taiwan.
  • Department of Surgery, Asian University Hospital, Asian University, Taichung City, Taiwan.
  • School of Medicine, China Medical University, Taichung City, Taiwan.

Zitieren

APA

Hsu, S. C., Chen, S. H., Chen, T. H., Hsu, W. F., Wang, H. W., Yeh, C. C., Yang, H. R., Lai, H. C., & Jeng, L. B. (2026). Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving Strategy. Annals of Transplantation. https://doi.org/10.12659/aot.952135

Vancouver

Hsu SC, Chen SH, Chen TH, Hsu WF, Wang HW, Yeh CC, et al. Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving Strategy. Annals of Transplantation. 2026. doi:10.12659/aot.952135

BibTeX
@article{Hsu2026,
  author = {Hsu, Shih-Chao and Chen, Sheng-Hsien and Chen, Te-Hong and Hsu, Wei-Fan and Wang, Hung-Wei and Yeh, Chun-Chieh and Yang, Horng-Ren and Lai, Hsueh-Chou and Jeng, Long-Bin},
  title = {Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving Strategy},
  journal = {Annals of Transplantation},
  year = {2026},
  doi = {10.12659/aot.952135}
}
Kostenlos starten →